+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccines - Global Market Outlook (2018-2027)

  • ID: 5017524
  • Report
  • March 2020
  • Region: Global
  • 185 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Astrazeneca
  • Bharat Biotech
  • CSL Limited
  • Glaxosmithkline PLC
  • Merck & Co Inc
  • Pfizer Inc
  • MORE
The Global Vaccines market accounted for $38.36 billion in 2018 and is expected to reach $81.27 billion by 2027 growing at a CAGR of 8.7% during the forecast period. While the factors like growing awareness on immunization, strong vaccine pipeline and the increasing focus of the key pharmaceutical players to develop innovative vaccines are driving the growth of the market. However, the huge capital investments required for developing vaccines may restrain the market growth. Moreover, the high growth prospects in emerging markets and an increase in the adoption of combination vaccines in prevention strategies by the government provide new growth opportunities in the future.

Vaccines are a powerful way to protect billions of people against many diseases that can be very dangerous and even deadly. A vaccine recognizes foreign invaders and releases the antibodies to destroy them and also provides immunity against that particular disease in the future. Most of the vaccines are given by injection, but some are given orally or nasally.

Based on the distribution channel, the hospital & retail pharmacies are likely to have a huge demand in the forecast period because vaccinations are a shorter duration procedure often conducted at smaller institutions. Also, people prefer nearby vaccination access. Hospital & retail pharmacies across the globe are under government surveillance to ensure vaccines demand is met and have adequate vaccine stock. By geography, North America is estimated to have a huge demand owing to the high prevalence of infectious diseases and growing investments by government and non-government organizations for vaccine development.

Some of the key players in Vaccines Market include Johnson & Johnson, Astrazeneca, Mitsubishi Tanabe Pharma Corporation, Sanofi Pasteur SA, CSL Limited, Emergent Biosolutions Inc, Panacea Biotec LTD, Bharat Biotech, Serum Institute of India Pvt LTD, Bavarian Nordic, Glaxosmithkline PLC, Daiichi Sankyo Company Limited, Pfizer Inc, Biological E, and Merck & Co Inc.

Types Covered:
  • Multivalent Vaccines
  • Monovalent Vaccines
Patient Types Covered:
  • Adult Patients
  • Pediatric Patients
  • Traveler Vaccines
Technologies Covered:
  • Conjugate Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Polysaccharide Vaccines
  • Inactivated & Subunit Vaccines
  • Live Attenuated Vaccines
  • Viral Vaccines
Distribution Channels Covered:
  • Government Suppliers
  • Hospital & Retial Pharmacies
Route of Administration Covered:
  • Intradermal
  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Other Routes of Administration
Disease Indications Covered:
  • Cancer
  • Cholera
  • Dengue
  • Diphtheria, Pertussis, and Tetanus (DTP)
  • Hepatitis
  • Herpes Zoster
  • Human Papilloma Virus (HPV)
  • Influenza
  • Measles, Mumps, and Rubella (MMR)
  • Meningococcal Disease
  • Pneumococcal Disease
  • Polio
  • Rabies
  • Rotavirus
  • Typhoid Fever
  • Varicella
Regions Covered:

North America
  • US
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings:

Purchasers of this report will be entitled to receive one of the following free customization options:

1. Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
2. Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
3. Competitive - Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astrazeneca
  • Bharat Biotech
  • CSL Limited
  • Glaxosmithkline PLC
  • Merck & Co Inc
  • Pfizer Inc
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Vaccines Market, By Type
5.1 Introduction
5.2 Multivalent Vaccines
5.3 Monovalent Vaccines

6 Global Vaccines Market, By Technology
6.1 Introduction
6.2 Conjugate Vaccines
6.3 Recombinant Vaccines
6.4 Toxoid Vaccines
6.5 Polysaccharide Vaccines
6.6 Inactivated & Subunit Vaccines
6.7 Live Attenuated Vaccines
6.8 Viral Vaccines

7 Global Vaccines Market, By Distribution Channel
7.1 Introduction
7.2 Government Suppliers
7.3 Hospital & Retial Pharmacies

8 Global Vaccines Market, By Route of Administration
8.1 Introduction
8.2 Intradermal
8.3 Intramuscular and Subcutaneous Administration
8.4 Oral Administration
8.5 Other Routes of Administration
8.5.1 Transcutaneous (TC)
8.5.2 Nasal Route

9 Global Vaccines Market, By Disease Indication
9.1 Introduction
9.2 Cancer
9.3 Cholera
9.4 Dengue
9.5 Diphtheria, Pertussis, and Tetanus (DTP)
9.6 Hepatitis
9.7 Herpes Zoster
9.8 Human Papilloma Virus (HPV)
9.9 Influenza
9.10 Measles, Mumps, and Rubella (MMR)
9.11 Meningococcal Disease
9.12 Pneumococcal Disease
9.13 Polio
9.14 Rabies
9.15 Rotavirus
9.16 Typhoid Fever
9.17 Varicella

10 Global Vaccines Market, By End User
10.1 Introduction
10.2 Adult Vaccines
10.3 Pediatric Vaccines
10.4 Traveler Vaccines

11 Global Vaccines Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Johnson & Johnson
13.2 Astrazeneca
13.3 Mitsubishi Tanabe Pharma Corporation
13.4 Sanofi Pasteur SA
13.5 CSL Limited
13.6 Emergent Biosolutions Inc
13.7 Panacea Biotec LTD
13.8 Bharat Biotech
13.9 Serum Institute of India Pvt LTD
13.10 Bavarian Nordic
13.11 Glaxosmithkline PLC
13.12 Daiichi Sankyo Company Limited
13.13 Pfizer Inc
13.14 Biological E
13.15 Merck & Co Inc

List of Tables
Table 1 Global Vaccines Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Vaccines Market Outlook, By Type (2017-2027) ($MN)
Table 3 Global Vaccines Market Outlook, By Multivalent Vaccines (2017-2027) ($MN)
Table 4 Global Vaccines Market Outlook, By Monovalent Vaccines (2017-2027) ($MN)
Table 5 Global Vaccines Market Outlook, By Technology (2017-2027) ($MN)
Table 6 Global Vaccines Market Outlook, By Conjugate Vaccines (2017-2027) ($MN)
Table 7 Global Vaccines Market Outlook, By Recombinant Vaccines (2017-2027) ($MN)
Table 8 Global Vaccines Market Outlook, By Toxoid Vaccines (2017-2027) ($MN)
Table 9 Global Vaccines Market Outlook, By Polysaccharide Vaccines (2017-2027) ($MN)
Table 10 Global Vaccines Market Outlook, By Inactivated & Subunit Vaccines (2017-2027) ($MN)
Table 11 Global Vaccines Market Outlook, By Live Attenuated Vaccines (2017-2027) ($MN)
Table 12 Global Vaccines Market Outlook, By Viral Vaccines (2017-2027) ($MN)
Table 13 Global Vaccines Market Outlook, By Distribution Channel (2017-2027) ($MN)
Table 14 Global Vaccines Market Outlook, By Government Suppliers (2017-2027) ($MN)
Table 15 Global Vaccines Market Outlook, By Hospital & Retial Pharmacies (2017-2027) ($MN)
Table 16 Global Vaccines Market Outlook, By Route of Administration (2017-2027) ($MN)
Table 17 Global Vaccines Market Outlook, By Intradermal (2017-2027) ($MN)
Table 18 Global Vaccines Market Outlook, By Intramuscular and Subcutaneous Administration (2017-2027) ($MN)
Table 19 Global Vaccines Market Outlook, By Oral Administration (2017-2027) ($MN)
Table 20 Global Vaccines Market Outlook, By Other Routes of Administration (2017-2027) ($MN)
Table 21 Global Vaccines Market Outlook, By Transcutaneous (TC) (2017-2027) ($MN)
Table 22 Global Vaccines Market Outlook, By Nasal Route (2017-2027) ($MN)
Table 23 Global Vaccines Market Outlook, By Disease Indication (2017-2027) ($MN)
Table 24 Global Vaccines Market Outlook, By Cancer (2017-2027) ($MN)
Table 25 Global Vaccines Market Outlook, By Cholera (2017-2027) ($MN)
Table 26 Global Vaccines Market Outlook, By Dengue (2017-2027) ($MN)
Table 27 Global Vaccines Market Outlook, By Diphtheria, Pertussis, and Tetanus (DTP) (2017-2027) ($MN)
Table 28 Global Vaccines Market Outlook, By Hepatitis (2017-2027) ($MN)
Table 29 Global Vaccines Market Outlook, By Herpes Zoster (2017-2027) ($MN)
Table 30 Global Vaccines Market Outlook, By Human Papilloma Virus (HPV) (2017-2027) ($MN)
Table 31 Global Vaccines Market Outlook, By Influenza (2017-2027) ($MN)
Table 32 Global Vaccines Market Outlook, By Measles, Mumps, and Rubella (MMR) (2017-2027) ($MN)
Table 33 Global Vaccines Market Outlook, By Meningococcal Disease (2017-2027) ($MN)
Table 34 Global Vaccines Market Outlook, By Pneumococcal Disease (2017-2027) ($MN)
Table 35 Global Vaccines Market Outlook, By Polio (2017-2027) ($MN)
Table 36 Global Vaccines Market Outlook, By Rabies (2017-2027) ($MN)
Table 37 Global Vaccines Market Outlook, By Rotavirus (2017-2027) ($MN)
Table 38 Global Vaccines Market Outlook, By Typhoid Fever (2017-2027) ($MN)
Table 39 Global Vaccines Market Outlook, By Varicella (2017-2027) ($MN)
Table 40 Global Vaccines Market Outlook, By End User (2017-2027) ($MN)
Table 41 Global Vaccines Market Outlook, By Adult Vaccines (2017-2027) ($MN)
Table 42 Global Vaccines Market Outlook, By Pediatric Vaccines(2017-2027) ($MN)
Table 43 Global Vaccines Market Outlook, By Traveler Vaccines (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Johnson & Johnson
  • Astrazeneca
  • Mitsubishi Tanabe Pharma Corporation
  • Sanofi Pasteur SA
  • CSL Limited
  • Emergent Biosolutions Inc
  • Panacea Biotec LTD
  • Bharat Biotech
  • Serum Institute of India Pvt LTD
  • Bavarian Nordic
  • Glaxosmithkline PLC
  • Daiichi Sankyo Company Limited
  • Pfizer Inc
  • Biological E
  • Merck & Co Inc
Note: Product cover images may vary from those shown
Adroll
adroll